XML 33 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair value measurement (Tables)
3 Months Ended
Mar. 31, 2024
Fair value measurement  
Schedule of assets and liabilities measured at fair value on recurring basis

 

Quoted prices
in active
markets
(Level 1)

 

Significant
other
observable
inputs
(Level 2)

 

Significant
unobservable
inputs
(Level 3)

 

Total

 

Classification in Consolidated
balance sheets

(in thousands)

At December 31, 2023

Assets:

Cash and cash equivalents

$

241,360

$

$

$

241,360

Cash and cash equivalents

Restricted cash

3,184

3,184

Other non-current assets

Total assets

$

244,544

$

$

$

244,544

Liabilities:

Contingent consideration

43,006

43,006

Contingent consideration

Consideration for post-acquisition services

457

457

Other non-current liabilities

Total liabilities

$

$

$

43,463

$

43,463

At March 31, 2024

Assets:

Cash and cash equivalents

$

243,062

$

$

$

243,062

Cash and cash equivalents

Restricted cash

3,167

3,167

Other non-current assets

Total assets

$

246,229

$

$

$

246,229

Liabilities:

Contingent consideration

42,212

42,212

Contingent consideration

Consideration for post-acquisition services

498

498

Other non-current liabilities

Total liabilities

$

$

$

42,710

$

42,710

Schedule of changes in fair value of contingent consideration

Amount of

contingent

consideration

2024

(in thousands)

Balance at December 31, 2023

$

43,006

Change in fair value (presented within research and development expenses)

165

Currency translation effects

(959)

Balance at March 31, 2024

$

42,212